INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Consensus Integra LifeSciences Holdings Corporation

Stocks

IART

US4579852082

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 12:41:10 20/10/2026 am IST			5-day change	1st Jan Change
13.42 ^USD	+1.59%		-4.11%	+7.93%

14/10	Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19	MT
12/10	Integra LifeSciences Prices $450 Million in Senior Secured Notes Due 2033	MT

Evolution of the Average Target: Integra LifeSciences Holdings Corporation

Evolution of the Target Price: Integra LifeSciences Holdings Corporation

Changes in Analyst Recommendations: Integra LifeSciences Holdings Corporation

a423b4c2ec.SZhupy8-Ik03fVpnGnVOkpnjEA7CXjzJI1MlaTRFyzY.ecpf6Bx4VjRFTmk3WR4D1ujWXGfvEm-EGxhUEGUr-3InwBnXcG5qOWgiHw~5d59aa7e636181973dbded258eea7790

Analysts' recommendations: Integra LifeSciences Holdings Corporation

14/10	Truist Securities Adjusts Integra LifeSciences Price Target to $15 From $19	MT
30/07	BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating	MT
28/07	UBS Initiates Coverage on Integra LifeSciences With Neutral Rating, $19 Price Target	MT
16/07	Truist Adjusts Price Target on Integra LifeSciences Holdings to $19 From $14, Maintains Hold Rating	MT
09/07	BMO Capital Initiates Integra LifeSciences at Market Perform With $19 Price Target	MT
19/06	Integra LifeSciences Shares Rise After Upgrade From Argus Research	MT
18/06	Argus Research Upgrades Integra LifeSciences to Buy From Hold, $25 Price Target	MT
28/05	Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Adjusts Price Target to $16 From $11	MT
06/05	Truist Adjusts Price Target on Integra LifeSciences to $14 From $12, Maintains Hold Rating	MT
15/04	Truist Cuts Price Target on Integra LifeSciences Holdings to $12 From $13, Keeps Hold Rating	MT
12/01	Canaccord Genuity Initiates Coverage on Integra LifeSciences With Speculative Buy Rating, CA$9.25 Price Target	MT
31/25/31	Medtech firm Integra's Q2 revenue beats expectations	RE
13/25/13	Morgan Stanley Adjusts Price Target on Integra LifeSciences Holdings to $10 From $20, Maintains Equalweight Rating	MT
06/25/06	Top Midday Decliners	MT
11/25/11	Truist Cuts Price Target on Integra LifeSciences Holdings to $19 From $26, Keeps Hold Rating	MT
31/25/31	Argus Upgrades Integra LifeSciences to Buy From Hold, Price Target is $28	MT
06/24/06	Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating	MT
14/24/14	Correction: Truist Trims Price Target on Integra LifeSciences Holdings to $21 From $26, Keeps Hold Rating	MT
14/24/14	Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating	MT
07/24/07	BTIG Upgrades Integra LifeSciences Holdings to Neutral From Sell	MT
30/24/30	BTIG Downgrades Integra LifeSciences Holdings to Sell From Neutral, Price Target is $22	MT
30/24/30	Citigroup Downgrades Integra LifeSciences Holdings to Sell From Neutral, Adjusts Price Target to $23 From $30	MT
30/24/30	Analyst recommendations: 3M Company, Aon, Murphy USA, Skyworks, Tesla...
30/24/30	Truist Adjusts Price Target on Integra LifeSciences Holdings to $26 From $32 After 'Big' H2 Guide Cut, Maintains Hold Rating	MT
16/24/16	Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	INTEGRA LIFESCIENCES HOLDINGS CORPORATION					+36.26%
	ABBOTT LABORATORIES					+15.09%
	MEDTRONIC PLC					+10.41%
	STRYKER CORPORATION					+23.06%
	ESSILORLUXOTTICA					+43.42%
	CENCORA, INC.					+7.85%
	HOYA CORPORATION					+16.96%
	BECTON, DICKINSON AND COMPANY					+1.21%
	IDEXX LABORATORIES, INC.					+25.9%
	DEXCOM, INC.					+12.11%
	Average					+19.23%
	Weighted average by Cap.					+17.70%